The reduced binding of the LEDGF/menin/MLL-fusion complex and increased binding of myeloid transcription factors were associated with myeloid differentiation of LSCs and enhanced AML sensitivity to menin inhibition. This evidence concerns the gene KMT2A and acute myeloid leukemia.